Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply

Mi Na Kim; Sang Hoon Ahn

doi:10.1111/apt.16765

Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	481-482
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	55
Issue number	4
DOIs	https://doi.org/10.1111/apt.16765
Publication status	Published - 2022 Feb

Bibliographical note

Funding Information:
The authors' declarations of personal and financial interests are unchanged from those in the original article.2

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.16765

Cite this

@article{9263071839634498acc3cdb2d19abe65,

title = "Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply",

author = "Kim, {Mi Na} and Ahn, {Sang Hoon}",

note = "Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article.2",

year = "2022",

month = feb,

doi = "10.1111/apt.16765",

language = "English",

volume = "55",

pages = "481--482",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Editorial

T2 - concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply

AU - Kim, Mi Na

AU - Ahn, Sang Hoon

N1 - Funding Information: The authors' declarations of personal and financial interests are unchanged from those in the original article.2

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85123860122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123860122&partnerID=8YFLogxK

U2 - 10.1111/apt.16765

DO - 10.1111/apt.16765

M3 - Editorial

C2 - 35092057

AN - SCOPUS:85123860122

SN - 0269-2813

VL - 55

SP - 481

EP - 482

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 4

ER -

Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this